Skip to main content
. 2018 Aug 10;6(8):E1020–E1030. doi: 10.1055/a-0614-2202

Table 1. Clinical features according to the type of drainage catheter (including all 371 patients).

c-ENBD (7-Fr) m-ENBD (6-Fr)
Variables (n = 242) (n = 129) P value
Age, y (range) 0.756
 69 (34 – 83)  68 (35 – 90)
Gender (%) 0.100
  • Male

148 (61.2)  90 (69.8)
  • Female

 94 (38.8)  39 (30.2)
Bismuth-Corlette criteria, n (%) 0.040
  • I, II

 50 (20.7)  39 (28.1)
  • III, IV

192 (79.3)  90 (69.8)
Pre-ENBD cholangitis (%) 0.512
  • With

 34 (14.0)  15 (11.6)
  • Without

208 (86.0) 114 (88.4)
Pre-ENBD total serum bilirubin (%) 0.926
  •  ≥ 2 mg/dL

 95 (39.3)  50 (38.8)
  •  < 2 mg/dL

147 (60.7)  79 (61.2)
Previous EBS (%) 0.356
  • With

102 (42.1)  48 (37.2)
  • Without

140 (57.9)  81 (62.8)
Previous ENBD (%) 0.863
  • With

 43 (17.8)  22 (17.1)
  • Without

199 (82.2) 107 (82.9)
Previous EST (%) 0.570
  • With

 84 (34.7)  41 (31.8)
  • Without

158 (65.3)  88 (68.2)
Pancreatography (%) 0.029
  • Present

 91 (37.6)  34 (26.4)
  • Absent

151 (62.4)  95 (73.6)
Duration of ENBD, d (range) 0.039
 29 (2 – 96)  33 (3 – 144)
Catheter dislocation (%) 0.073
  • Occurred

  6 (2.5)   8 (6.2)
  • Not occurred

236 (97.5) 121 (93.8)
Catheter impaction (%) 0.071
  • Occurred

 19 (7.9)   4 (3.1)
  • Not occurred

223 (92.1) 125 (96.9)
Subsequent and/or additional drainage 0.123
  • Required

 58 (24.0)  22 (17.1)
  • Not required

184 (76.0) 107 (82.9)
Post-ENBD cholangitis (%) 0.006
  • With

 59 (24.4)  16 (12.4)
  • Without

183 (75.6) 113 (87.6)
Post-ENBD pancreatitis (%) 0.968
  • With

 39 (16.1)  21 (16.3)
  • Without

203 (83.9) 108 (83.7)

ENBD, endoscopic nasobiliary drainage; c-ENBD, conventional ENBD catheter; m-ENBD, modified ENBD catheter; EBS, endoscopic biliary stenting; EST, endoscopic sphincterotomy